PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34539991-8	2021	Mechanistically, galangin inhibited the activation of the JNK and ERK MAPK pathways and nuclear factor kappa-B (NF-kappaB) signaling pathway.	galangin	17-25	mitogen-activated protein kinase 1	Mus musculus	66-69	
34539991-8	2021	Mechanistically, galangin inhibited the activation of the JNK and ERK MAPK pathways and nuclear factor kappa-B (NF-kappaB) signaling pathway.	galangin	17-25	mitogen-activated protein kinase 1	Mus musculus	70-74	
34539991-10	2021	Conclusion: Galangin suppressed the IL-beta-induced inflammatory response in vitro and ameliorated cartilage degeneration in vivo via inhibiting the NF-kappaB pathway and JNK and ERK pathways, suggesting its potential as an effective candidate for the treatment of OA.	galangin	12-20	mitogen-activated protein kinase 1	Mus musculus	179-182	
28558962-0	2017	Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.	galangin	0-8	mitogen-activated protein kinase 1	Mus musculus	145-148	
25270721-10	2014	Galangin was found to elicit anti-inflammatory effects by inhibiting ERK and NF-kappaB-p65 phosphorylation.	galangin	0-8	mitogen-activated protein kinase 1	Mus musculus	69-72